Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  6. News
  7. Summary
    300760   CNE100003G67

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

(300760)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Mindray Announces the Launch of its Latest Point-Of-Care Ultrasound System, the TE9

09/10/2021 | 01:00am EST

Mindray announced the launch of its latest Point-of-Care (POC) ultrasound system, the TE9, featuring a larger screen for enhanced viewing, intelligent tools for fast-paced environments, and the industry's first Auto GA (Gastric Antrum). Auto GA automatically identifies the edge of the gastric antrum and calculates the area with a single screen tap, helpful for evaluating gastric content and of great clinical value for quick decisions regarding patient suitability for surgery. TE9's numerous features include: Quick and Clear Diagnoses: Superior imaging and transducer technology enable quick and precise diagnoses in various clinical scenarios. TE9's large 21.5-inch high-definition touch screen gives clinicians a clear and confident view from anywhere in the examination room. Smart and Efficient Workflow: A comprehensive suite of smart automation tools such as Auto GA, Smart IVC, and more, allow clinicians to quickly evaluate a patient's conditions at bedside, in the OR, or on the move. With these advanced tools, the TE9 ensures rapid, reproducible measurements for confident exams and procedures, even in fast-paced environments. Innovative Design: TE9's iVocal voice commands enable handsfree commands to be issued for faster response times. Meanwhile, its comprehensive disinfection capabilities are suitable for use in environments that require frequent disinfection, providing ideal clinical utility and allowing for a quick turnaround time between examinations. Seamless Connectivity: The eGateway Integration Solution seamlessly connects the TE9 to the hospital's network, enabling clinicians to easily and securely access patient data and send exam information, images, and reports to the EMR system. This paperless process supports streamlined clinical decision-making, improves workflow and productivity, and reduces the risk of manual transcription errors. Together with TE7, which has demonstrated versatility in all specialties in large public healthcare institutions worldwide, TE9 is set to bring clinical efficiency and diagnostic confidence to a new level for the industry with more upgraded features as the newest member of Mindray's TE product range.


ę S&P Capital IQ 2021
All news about SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
10/19Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Nin..
CI
10/16Certain A Shares of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. are subject to a..
CI
09/27Mindray Launches New MC-80 Automated Digital Cell Morphology Analyzer, Taking Morpholog..
CI
09/22Shenzhen Mindray Bio-Medical Electronics Co., Ltd. completed the acquisition of HyTest ..
CI
09/10Mindray Announces the Launch of its Latest Point-Of-Care Ultrasound System, the TE9
CI
09/02Tranche Update on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s Equity Buyback P..
CI
09/01Shenzhen Mindray Bio-Medical Electronics Co., Ltd.'s Equity Buyback announced on August..
CI
08/25Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announces an Equity Buyback for CNY ..
CI
08/25Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Reports Earnings Results for the Hal..
CI
08/24Shenzhen Mindray Bio-Medical Electronics Co., Ltd. authorizes a Buyback Plan.
CI
More news
Analyst Recommendations on SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
More recommendations
Financials
Sales 2021 25 566 M 4 030 M 4 030 M
Net income 2021 8 242 M 1 299 M 1 299 M
Net cash 2021 22 374 M 3 527 M 3 527 M
P/E ratio 2021 52,5x
Yield 2021 0,69%
Capitalization 430 B 67 835 M 67 836 M
EV / Sales 2021 16,0x
EV / Sales 2022 12,9x
Nbr of Employees 11 833
Free-Float 31,7%
Chart SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Duration : Period :
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 354,90 CNY
Average target price 481,45 CNY
Spread / Average Target 35,7%
EPS Revisions
Managers and Directors
Ming He Cheng General Manager & Director
Xi Ting Li Chairman
Zhi Tang Chairman-Supervisory Board
Hao Xi Independent Director
Hang Xu Director
Sector and Competitors